Featured Stories
Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Another lawsuit has been filed over adverse Plavix side effects. The lawsuit, filed by national law firm Parker Waichman LLP, alleges that the blood thinner, Plavix (clopidogrel), caused an Oklahoma man to suffer from multiple stomach bleeds.

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Oklahoma Woman Latest to Head to Court Over Alleged DePuy ASR Hip Implant Injuries

Oklahoma Woman Latest to Head to Court Over Alleged DePuy ASR Hip Implant Injuries

Lawsuits filed by alleged victims of DePuy Orthopaedics’ recalled ASR hip replacement devices continue to pile up in the multidistrict litigation currently underway in U.S. District Court, Northern District of Ohio. Most recently, a woman from Pryor, Oklahoma, filed suit alleging complications caused by a DePuy ASR hip implant ...

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

Otterbox Settles Whistleblower Lawsuit for $4.3M

Otterbox_Settles_Lawsuit_for_$4.3MOtter Products LLC, the company that makes OtterBox smartphone and tablet cases, has settled a whistleblower lawsuit alleging that the company violated federal law by underpaying customs duties, North Colorado Business Report reports. According to U.S. Attorney John Walsh’s office, the company has paid $4.3 million to the U.S. government. The statement was announced Monday by the U.S. Attorney’s Office for the District of Colorado, Department of Homeland Security and U.S. Customs and Border Protection. Continue reading

Posted in Legal News |

Generic-Drug Failure Prompts FDA to take Action

FDA_takes_action_Generic_Drug_FailureGeneric drugs, non-name brand medications that cost far less than the brand-name, came under greater scrutiny recently after the U.S. Food and Drug Administration (FDA) banned imports of treatments made from two Indian facilities (Ranbaxy Labs and Wockhardy Ltd). The agency was forced to halt sale of generic drugs from these facilities due to drug safety. This spurred fear in the FDA and consumers alike, who are less likely to take generic drugs if they develop a reputation for being dangerous-even if they safe and just as effective. Generic medications make up nearly 80 percent of US prescriptions. Continue reading

Posted in Legal News |

Disabled Man Settles Delta Lawsuit, Alleges He Was Forced to Crawl On and Off Two Separate Flights

Disabled_Man_Settles_Delta_LawsuitA partially paralyzed man claims that Delta Airlines workers forced him to crawl on and off two flights in 2012. The lawsuit, brought in 2013, has just been settled.

The Maui man sued Delta over allegations that airline workers forced him to crawl on and off the flights the prior year and that the airline did not provide a wheelchair or other assistance on either of the 2012 flights, according to the Associated Press (AP). Continue reading

Posted in Legal News |

This Saturday is Prescription Drug Take-Back Day

DEA-National-Prescription-Drug-Take-Back-Day-April-2014National Prescription Drug Take-Back Day is scheduled for April 24th from 10:00 a.m. to 2:00 p.m., local time. The program seeks to offer a safe, convenient, and responsible way in which to dispose of prescription medications, according to the Department of Justice

The program is also meant to educate the general public about the potential likelihood of medication abuse, the Department of Justice indicates. Appropriately disposing of medications helps fight one of the key ways in which young people access drugs and develop substance abuse problems, wrote the Mercury News. Continue reading

Posted in Pharmaceuticals |

Study: Codeine Use in Children Poses Dangers

Codeine_Poses_Dangers_in_ChildrenAlthough there are recommended limits on codeine use in children, a new study reveals that codeine is prescribed to pediatric patients in at least 500,000 emergency room visits annually.

According to the decade-long study, in 2010 alone, 3 percent of pediatric emergency room visits led to a codeine prescription. With over 25 million ER visits involving children annually, too many children are being prescribed the painkiller, the study authors say, according to the Associated Press (AP). What’s more, there are better options available for children, the researchers note. Continue reading

Posted in Pharmaceuticals |

e-Cigarette Ban Sought in Glen Cove, New York

e-Cigarette_Ban_Sought_in_Glen_Cove_New_YorkMayor Reginald Spinello of Long Island’s Glen Cove seeks to include e-cigarettes under ordinances that also include traditional cigarette bans.

Mayor Spinello told Newsday that Glen Cove’s city ordinances should be amended and that the town attorney will be looking at the language necessary for a City Council resolution that would ensure that Glen Cove city’s anti-smoking ordinances would be more comprehensive.

“The hope is that when we talk about ‘no smoking’ they should say that includes e-cigarettes, too,” the mayor told Newsday. The mayor seeks to have Glen Cove follow in the examples of other municipalities that have enacted comparable prohibitions.
Continue reading

Posted in Defective Products |

Fresenius Recalls NaturaLyte Sodium Bicarbonate Liquid Concentrate Due to Bacterial Contamination

Fresenius_Recalls_NaturaLyte_Due_to_Bacterial_ContaminationHealth Canada, Canada’s federal health agency, has announced that Fresenius Medical Care is voluntarily recalling specific lots of NaturaLyte Sodium Bicarbonate Liquid Concentrate in 6.4L and 8L sizes due to bacterial contamination.

This product is used in kidney dialysis (hemodialysis) to remove waste products from the blood by passing them out of the body through a filtering system. The affected product (lots 13JMLB004, 13JMLB006, 13JMLB007 and 13JMLB008) was distributed to hospital and home settings between August 8, 2013 and October 28, 2013, with expiration dates that run from June through December 2014. Fresenius advises users to check lot numbers before administering the product and immediately discontinue use of affected lots. Recalled products should be stored in a secured area, away from other products, until they can be returned to Fresenius. Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Product Recalls, Recalled Drugs |

Older COPD Patients May Suffer from More Breathing Problems when taking Certain Sedatives, Study Shows

Older_Patients_Suffer from_Breathing Problems_with_Certain_SedativesOlder adults who suffer from chronic obstructive pulmonary disease (COPD) may be more likely to suffer from serious breathing problems if they take certain sedatives, new research suggests. According to a study published on Thursday in the European Respiratory Journal,benzodiazepines such as lorazepam (Ativan) or alprazolam (Xanax) are associated with a 45 percent increased risk of breathing problems that require outpatient treatment in older COPD patients. These patients were also 92 percent more likely go to the emergency room for pneumonia or COPD, and had a higher risk of being hospitalized for breathing problems. Continue reading

Posted in Legal News |

Class I Recall: Spacelabs Healthcare Ltd., ARKON Anesthesia Delivery System

arkon_system_recallThe U.S Food and Drug Administration (FDA) just announced that Spacelabs Healthcare Ltd. has recalled its ARKON Anesthesia Delivery System with Version 2.0 Software. A software defect may cause the system to cease working. The FDA has deemed the recall a Class I, its most serious designation, which is reserved for situations in which there exists a reasonable probability that use of the recalled product will cause serious adverse health consequences or death.

The recalled ARKON Anesthesia Delivery Systems were manufactured and distributed from March 18, 2013 through June 17, 2013; 16 units were distributed to hospitals in North Carolina and South Carolina. The ARKON Anesthesia Delivery System with Version 2.0 Software includes the following serial numbers of units distributed in the United States: Continue reading

Posted in Defective Medical Devices, Product Recalls, Recalled Medical Devices |

Alarming Rate of Use of Antipsychotic Drugs in Nursing Homes

overuse_of_Antipsychotic_Drugs_in_Nursing_HomesA Canadian newspaper’s investigative report reveals an alarming increase in the use of powerful antipsychotic drugs in nursing homes, despite warnings that these medications are dangerous – even lethal – for elderly patients with dementia.

The Toronto Star (thestar.com) found that some long-term care facilities, often short staffed, routinely use these drugs to calm and “restrain” wandering, agitated and sometimes aggressive patients. The Star found that as many as one half of residents at some facilities are on antipsychotics. Continue reading

Posted in Health Concerns, Nursing Home Abuse |